Showing results (41-50 of 196) with videos related to

Sort By:
Pageof 20
Journal of Medical Virology|May 9, 2015
Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapySatoshi Yoshimi, Michio Imamura, Eisuke Murakami, et al.
Frontiers in Pharmacology|June 26, 2026
Pharmacological profiling of intravenous MP-04: sustained NAD<sup>+</sup> augmentation, immune modulation, and renal protection in preclinical modelsAlip Ghosh, Gautham Pranesh, Nikhil Zachariah, et al.
Journal of Virology|April 13, 2012
Structure of hepatitis C virus polymerase in complex with primer-template RNARalph T Mosley, Thomas E Edwards, Eisuke Murakami, et al.
BMC Gastroenterology|August 26, 2024
Predictive factors of portal hypertensive enteropathy exacerbations based on long-term outcomesYuka Matsubara, Akiyoshi Tsuboi, Issei Hirata, et al.
Oncology|June 27, 2019
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with LenvatinibKenichiro Kodama, Tomokazu Kawaoka, Maiko Namba, et al.
Drug Metabolism and Pharmacokinetics|April 30, 2020
Species differences in liver accumulation and metabolism of nucleotide prodrug sofosbuvirTing Wang, Darius Babusis, Yeojin Park, et al.
Journal of Pharmaceutical Health Care and Sciences|August 15, 2025
Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver diseaseYuuka Shibata, Yuki Koga, Yuki Sato, et al.
Antimicrobial Agents and Chemotherapy|September 4, 2014
Molecular and structural basis for the roles of hepatitis C virus polymerase NS5B amino acids 15, 223, and 321 in viral replication and drug resistanceAngela M Lam, Thomas E Edwards, Ralph T Mosley, et al.
Therapeutic Advances in Gastroenterology|March 13, 2025
Impact of viral eradication by direct-acting antivirals on clinical outcomes after curative treatment for hepatitis C virus-associated hepatocellular carcinomaYuko Nagaoki, Kenji Yamaoka, Yasutoshi Fujii, et al.
Journal of Gastroenterology|February 12, 2013
Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patientsMasataka Tsuge, Eisuke Murakami, Michio Imamura, et al.
Pageof 20